Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Lapatinib 1500 / Fulvestrant (500/250), Breast Cancer, Cycle 1

Protocol-ID: 1770 V1.0 (Mini), LAPA1500/FLVS(500/250), Breast Ca, C1

Indication(s)

  • Breast Cancer (HR+ postmenopausal, HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 17.04.2021